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ABSTRACT 
In the study, the possible effect of sodium valproate (NaVP) on urethane-induced lung tumors 
in mice has been evaluated. BALB/c mice (n = 120; 4–6 weeks old, both sexes) were used in 
the following groups: 1) urethane-treated, 2) urethane–NaVP-treated, 3) only NaVP-treated, 
4) control. In the same groups, castrated male mice (n = 48) were investigated. Urethane was 
given by intraperitoneal injections 10 mg/mouse, twice a week, the total dose 50 mg/mouse. 
In NaVP-treated mice, the 0.4 % NaVP aqueous solution was offered to mice ad libitum. The 
duration of the experiment was 6 months. The number of tumors per mouse in urethane–
NaVP-treated males was significantly higher than in those treated with urethane only (13.82 ± 
1.12 vs 6.77 ± 0.43, p < 0.0001). No significant difference in the number of tumors per mouse 
was revealed while comparing the female urethane- and urethane–NaVP-treated groups (6.50 
± 0.79 vs 8.15 ± 0.55, p = 0.105). No difference in the number of tumors per mouse was 
found in urethane–NaVP-treated castrated males as compared with urethane-treated castrated 
males. However, in the urethane–NaVP-treated castrated males the number of tumors per 
mouse was significantly lower than in analogous non-castrated males (7.8 ± 1.67 vs 13.82 ± 
1.12, p < 0.01). NaVP combined with urethane potentiates urethane tumorigenicity in 
BALB/c non-castrated but not in female and castrated male mice. These data indicate an im-
portant role of testosterone in the urethane-NaVP induced lung tumorigenesis. 
 
Keywords: sodium valproate, urethane, mice, lung tumorigenesis, gender differences 
 
 
INTRODUCTION 
Urethane-induced lung tumors in mice 
models have been accepted for human lung 
adenocarcinoma investigations (Malkinson, 
2001). BALB/c mice are considered as a 
medium susceptible for the development of 
lung tumor by urethane and can be modified 
by the potential modulatory agents (Mal-
kinson and Beer, 1983; Uleckiene et al., 
2005). There are no studies on the effect of 
sodium valproate (NaVP) on urethane-
induced lung tumors in mice. The aim of our 
study was to investigate the effect of NaVP 
on lung tumorigenesis induced by urethane, 
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a chemical lung carcinogen, in BALB/c mice 
of both genders. 
NaVP is a medicine preparation which 
currently is used for the treatment of a wide 
variety of neurological disorders (Evers, 
2008; Bowden, 2009). NaVP increases the 
turnover of gamma-aminobutyric acid 
(GABA) and thereby potentiates GABAergic 
functions (Loscher, 2002). GABA may af-
fect cancer growth by activating GABA re-
ceptors. The gene expression investigation of 
GABA receptors in tissues of non-small cell 
lung cancers showed the gene expression of 
GABA receptor phenotypes to be correlated 
with cancerogenesis and clinical prognosis 
(Zhang et al., 2013). Similarly, GABA stim-
ulates human hepatocellular carcinoma 
growth through the overexpressed GABA A 
receptor (Li et al., 2012). 
The GABA A receptor is an ionotropic 
receptor. Its subunits form a functional chlo-
ride channel (Fritschy and Mohler, 1995, Bu-
reu et al., 1997). The GABA A receptor is 
rapidly activated by NaVP in the brain cells 
(Armijo et al., 2000). The GABA A receptor 
subunits are expressed in Wistar rat kidney 
proximal convoluted and straight tubules and 
in other tissues (Sarang et al., 2001; Li et al., 
2012; Zhang et al., 2013). NaVP has shown 
to enhance the urinary excretion of sodium 
and chloride ions in Wistar rats of both gen-
ders, but the 24-hour chloriduretic response 
was found to be gender-related (Grikiniene 
et al., 2005). Chloride is recognized to have 
an important role in tumor genesis: the intra-
cellular chloride concentration would be one 
of the critical messengers in cell growth/pro-
liferation and differentiation processes 
(Shiozaki et al., 2006; Hiraoka et al., 2010; 
Ohsawa et al., 2010).  
Furthermore, NaVP defines a novel class 
of HDAC inhibitors that induce diffe-
rentiation of transformed cells and show an-
titumor properties in clinical and preclinical 
studies (Göttlicher et al., 2001; Kawagoe, 
2002; Santoro et al., 2013). In chronic rat 
and mouse studies using NaVP, an increased 
incidence of subcutaneous fibrosarcoma oc-
curred in male rats at the higher dosage level, 
and a dose-related trend for an increased in-
cidence of benign pulmonary adenomas was 
observed in male mice (McEvoy, 1991). 
Many aspects of the contribution of the 
NaVP pharmacological mechanisms and 
their significance in gender-related tumor-
igenesis have not been investigated.  
Our data have shown that NaVP together 
with urethane increases urethane tumori-
genicity in male but not in female mice. In 
contrast, in the groups of castrated males, no 
synergistic NaVP and urethane effect on 
lung tumor numbers was found. The possible 
mechanisms of the NaVP gender-related ef-
fect are discussed in the article. 
 
MATERIALS AND METHODS 
In the study, we used the BALB/c mouse 
lung adenoma assay which is one of the as-
says often used for investigating the possible 
cancer modulative agents. The examined 
BALB/c mice are characterized by a high 
sensitivity to the pulmonotropic carcinogen 
urethane. BALB/c mice (n = 120; 4–6 weeks 
old, both sexes) and castrated BALB/c male 
mice of similar age (n = 48) were used in the 
study. The animals were purchased from the 
Animal Facility of the Lithuanian University 
of Health Sciences, Veterinary Academy 
(Kaunas, Lithuania). The experiments were 
performed in compliance with the relevant 
laws and institutional guidelines. Permis-
sions of the State Food and Veterinary Ser-
vice of Lithuania to use experimental ani-
mals for research were obtained (No. 0177 
/30/04/2008/2 & 25/07/2013). Male castrat-
ion was performed by removing testes at the 
age of 5–6 weeks. The animals were housed 
in standard colony cages with free access to 
food and acclimatized for one week before 
the study; they were housed in the conditions 
of constant temperature (21  1 °C), humidi-
ty, and the light/dark cycle (12 h/ 12 h). A 
commercial pellet diet and fresh drinking 
water were provided ad libitum.  
NaVP was from Sigma-Aldrich Chemie 
GmbH, Germany, and urethane (ethyl car-
bamate) was from Fluka.  
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Intact male and female mice were ran-
domly divided into eight groups – four 
groups for each gender (n = 15 in a group):  
1) treated with urethane,  
2) treated with urethane plus NaVP,  
3) treated with NaVP only,  
4) intact control.  
In the same four groups (n = 15 per group), 
castrated male mice were investigated. In the 
urethane-treated groups, 10 mg ure-
thane/mouse in 0.2 ml sterile physiological 
solution was given twice a week by intra-
peritoneal injections (5 doses, total dose 
50 mg/mouse). The second and third groups 
of both genders were treated per os with 
NaVP 0.4 % aqueous solution (in the second 
group starting two weeks prior to urethane 
administration) for six months. The NaVP 
solution was offered to the animals ad libi-
tum (in aluminum foil-wrapped bottles to 
avoid light-induced decomposition). The 
control and urethane groups were given wa-
ter which was their only source of drinking. 
After six months, animals that survived were 
killed in a CO2 camera. Lungs were fixed in 
a 10 % buffered formalin solution. Random-
ly selected tumors were taken for histologi-
cal evaluation. Histological examination was 
performed in each case when observable 
lung pathology (suspected not identified or 
malignant tumor) was present. The percent-
age of animals with lung tumors, the mean 
number of tumors per tumor-bearing mouse, 
tumor growth and histological type were 
considered in both genders only in mice that 
survived up to the end of the experiment. 
The results were statistically processed using 
Student`s t-test. Data were expressed a mean 
± SEM. The difference at the value of p < 
0.05 was considered significant.  
 
RESULTS  
Mice survival in the study groups  
Non-castrated mice. Mice of both gen-
ders in control and NaVP-treated groups sur-
vived until the end of the experiment. In the 
male urethane-treated group, from 15 mice 
13 survived: one mouse died in the 4th and 
the other in the 5th month of the experiment. 
In the urethane–NaVP male group, 11 mice 
(three mice died in the 1st–3rd months and 
one in 5th month) survived. In the female 
urethane-treated group, five mice did not 
survive: three mice died in the 1st–3rd 
months, one in the 4th and one in the 5th 
month of the experiment. In the urethane–
NaVP-treated group, two mice perished (one 
in the 1st and the other in the 5th month). 
This implies that young animals are sensitive 
to urethane and urethane–NaVP toxicity. Au-
topsies of mice that perished during the 5th 
month revealed that in urethane- and ure-
thane–NaVP-treated groups benign lung tu-
mors had developed in all cases, but data on 
these animals were not taken for statistical 
assessment.  
Castrated male mice. Among castrated 
mice, all mice survived in the following 
groups: in the castrated control as well as in 
NaVP-treated and in urethane-treated groups. 
In the male urethane–NaVP-treated group, 
nine mice survived up to six months of the 
experiment (two mice died in the 2nd–3rd and 
four in the 3rd–4th months). The prevalence 
of perished mice in the urethane–NaVP-
treated group is indicative of the toxicity of 
this combination for castrated mice.  
 
Gender-related differences in the number 
of lung tumors per mouse in  
non-catstraded mice groups 
No mice with lung tumors were found in 
control animals of both genders and in 
NaVP-treated female groups. Four small (< 1 
mm) tumors were found in the lungs of two 
mice in the NaVP-treated male group (one in 
one mouse and three in the other).  
All urethane-treated mice of both genders 
developed tumors. No significant difference 
in the number of tumors (lung tumors per 
mouse) was detected when comparing ure-
thane-treated male and female mice groups 
(Table 1).  
Urethane-caused adenomas may be 
found in any lobe of a lung and are often sit-
uated just beneath the pleura, and are recog-
nized by their nodular, pearly, grey-white 
appearance contrasting with the more pink 
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color of the normal lung parenchyma (Figure 
1).  
When comparing the number of tumors 
per mouse in male mice treated with ure-
thane and those treated with urethane plus 
NaVP, lung tumors were found statistically 
significantly more often in males treated 
with urethane in combination with NaVP 
(6.77 ± 0.43 vs 13.82 ± 1.12, p < 0.0001; 
Table 1). The number of tumors per male 
mouse treated with urethane (n = 13) ac-
cording to tumor diameter was per subgroup 
as follows: 3.85 ± 0.32 in the subgroup with 
the tumor diameter ≤ 1.0 mm, 2.31 ± 0.45 in 
1.0 to 2.0 mm and 0.23 ± 0.17 in the > 2.0 
mm subgroup. In male urethane–NaVP-
treated mice (n = 11), the number of tumors 
per mouse was as follows: with the diameter 
≤ 1.0 mm 8.09 ± 0.94, with the diameter 1.0 
to 2.0 mm 5.45 ± 0.72, and with > 2.0 mm 
0.27 ± 0.14. NaVP in mice treated with ure-
thane caused an increase in the number of 
tumors per mouse in subgroups with the tu-
mor diameter ≤ 1.0 mm (p < 0.001) and 1.0 
to 2.0 mm (p < 0.001). This fact indicates 
that NaVP causes the formation of new tu-
mors and increases the progression of tumors 
in male BALB/c mice (Figure 2).  
No statistically significant difference was 
found when comparing the number of tumors 
per mouse in females treated with urethane 
and those treated with the urethane and 
NaVP combination (6.50 ± 0.79 vs 8.15 ± 
0.55, p = 0.105; Table 1). The number of 
tumors per female mouse treated with 
urethane (n = 10) according to tumor 
diameter was as follows: 4.20 ± 0.59 with 
tumor diameter ≤  1 mm, 1.90 ± 0.43 with 
the diameter 1.0 to 2.0 mm, and 0.4 ± 0.31 
with the diameter > 2.0 mm. In the female 
urethane–NaVP-treated group (n = 13), the 
number of tumors per mouse was as follows: 
5.0 ± 0.46 with the diameter ≤ 1 mm, 3.08 ± 
0.51 with the diameter 1.0 to 2.0 mm, and 
0.08 ± 0.08 with the diameter > 2.0 mm 
(Figure 2). 
No significant difference in the number 
of tumors per mouse was revealed while 
comparing the female urethane- and ure-
thane–NaVP-treated groups, both in general 
and in separate subgroups.  
 
 
 
 
Table 1: Incidence of lung tumors in BALB/c mice of the study groups 
Groups 
Initial data Data after 6 months 
n 
body 
weight (g) 
m ± SDEV 
n 
body 
weight (g) 
m ± SDEV 
mice with 
tumors 
(%) 
tumors in 
mouse 
m ± SEM 
Intact control: 
male 
female 
 
15 
15 
 
14.3 ± 2.3 
12.0 ± 1.5 
 
15 
15 
 
29.5 ± 1.9 
24.3 ± 1.1 
 
0 
0 
 
0 
0 
Urethane-treated: 
male 
female 
 
15 
15 
 
14.9 ± 1.7 
13.2 ± 1.1 
 
13 
10 
 
27.8 ± 2.7 
21.4 ± 2.9 
 
100 
100 
 
6.77 ± 0.43 
6.50 ± 0.79 
Urethane–NaVP-treated: 
male 
female 
 
15 
15 
 
15.9 ± 2.3 
13.6 ± 1.3 
 
11 
13 
 
26.6 ± 2.9 
20.4 ± 3.7 
 
100 
100 
 
13.82 ± 1.12*
8.15 ± 0.55**
NaVP-treated: 
male 
female 
 
15 
15 
 
12.5 ± 1.2 
11.4 ± 1.3 
 
15 
15 
 
27.7 ± 2.6 
20.0 ± 3.2 
 
13.3 
0 
 
0.19 ± 0.14 
0 
* p < 0.0001 in comparison with the male group given urethane only. 
** p < 0.01 in comparison with the male group given urethane–NaVP. 
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Figure 1: Lung specimens. A – control; B – urethane-induced lung multiple benign adenomas;  
C – lungs with advanced tumor (black arrowheads) – adenomas after urethane–NaVP treatment 
(white arrowheads); D – histological slide of lungs with benign adenoma. White arrowheads show well 
established borders of the tumor, black arrowheads – tumor cells with rounded regular nuclei, and ar-
rows show alveolar/bronchial hyperplasia (bar 50 µm); E – adenoma, higher magnification. Tumor 
cells have regular oval nuclei, in some places cells have papillary arrangement (bar 20 µm); F – pul-
monary adenocarcinoma. Black arrowheads show irregular borders of the tumor and invasive growth, 
white arrowheads – pleomorphic tumor cells (bar 50 µm); G – malignant tumor, higher magnification. 
Cells have pleomorphic nuclei, an increased number of nucleoli, some cells have very dark nuclei (bar 
20 µm). 
 
 
A comparison of tumor numbers in ure-
thane–NaVP-treated males and analogous 
data of the female group has shown a signifi-
cant difference in the following subgroups: 
the number of tumors was higher in males 
with the tumor diameter ≤ 1 mm (8.09 ± 0.94 
vs 5.0 ± 0.46, p < 0.01), in the subgroup with 
the diameter 1.0 to 2.0 mm (5.45 ± 0.72 vs 
3.08 ± 0.51, p < 0.01), and in the subgroup 
with the diameter > 2.0 mm (0.27 ± 0.14 vs 
0.08 ± 0.08, p < 0.01). These data show that 
the NaVP effect on lung tumorigenesis is 
gender-related. 
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The number of tumors per mouse in cas-
trated male groups 
Three spontaneous tumors were found in 
the lungs of two control mice (two tumors in 
one and one more in another mouse). Three 
mice with lung tumors were found in the 
NaVP-treated castrated male group. All ure-
thane-treated and urethane–NaVP-tretated 
mice developed tumors. No statistically 
significant difference was found when 
comparing the number of tumors per mouse 
in castrated male mice treated with urethane 
and in those treated with the urethane and 
NaVP combination. The number of tumors 
per castrated animals treated with urethane in 
subgroups according to tumor diameter 
showed no statistically significant difference 
as compared with data on the urethane–
NaVP-treated group (Table 2). 
 
 
Table 2: Incidence of lung tumors in castrated BALB/c male mice of the study groups  
Groups 
Data after 6 month 
n body weight (m ± SD) 
mice with 
tumor (%)
tumors per mouse (m ± SEM) 
all <1.0 (mm) 1.0–2.0 (mm) >2.0 (mm)
Castrated 
control 15 23.4 ± 2.4 13.3 0.2 ± 0.15 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 
Urethane-
treated 15 22.7 ± 3.6 100 8.0 ± 1.21 4.2 ± 0.7 3.8 ± 0.7 0.5 ± 0.2 
Urethane–
NaVP-treated 9 24.4 ± 4.6 100 7.8 ± 1.67 3.9 ± 1.7 3.4 ± 0.4 0.5 ± 0.6 
NaVP-treated 15 24.4 ± 2.5 6.7 0.13 ± 0.1 0 0.2 ± 0.2 0 
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Figure 2: Incidence of benign lung tumors in BALB/c mice of both genders in urethane- and in ure-
thane–NaVP-treated groups according to data on subgroups by tumor size (diameter ≤ 1.0 mm, 1.0 to 
2.0 mm and ≥ 2.0 mm). 
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No significant difference in the number 
of tumors per mouse was detected when 
comparing intact male control and castrated 
male control groups as well as non-castrated 
and castrated urethane-treated male groups 
(Tables 1 and 2; p > 0.05). When comparing 
the number of tumors per mouse in castrated 
male mice urethane–NaVP-treated and non-
castrated urethane–NaVP-treated groups, 
lung tumors were found statistically 
significantly more often in non-castrated 
males (7.8 ± 1.67 vs 13.82 ± 1.12, p < 0.01; 
Tables 1 and 2).  
 
Cases of malignant tumors 
A randomly selected histological exami-
nation performed in each case of observable 
lung pathology when not identified or malig-
nant tumors were suspected revealed several 
cases of lung tumor adenocarcinoma in non-
castrated urethane- and urethane–NaVP-
treated mice groups of both genders. Cases 
of adenocarcinoma (Figure 1) were identified 
by a histological examination of lungs and 
found to occur together with benign tumors.  
In castrated male mice, a few malignant 
tumors were found in NaVP-treated, ure-
thane-treated, and in urethane–NaVP-treated 
mice. Adenocarcinoma was revealed in cases 
when the tumor diameter was more than 
1.5 mm (results of a detailed histological ex-
amination of adenocarcinoma cases will be 
published separately upon analysing all tu-
mors in all mice groups).  
 
DISCUSSION 
Urethane is a chemical carcinogen pre-
sent in tobacco leaves, tobacco smoke 
(Schmetiz et al., 1978), formed by the reac-
tion of urea with alcohol (Wang et al., 2007). 
Urethane specifically initiates the develop-
ment of lung tumors from airway epithelial 
cells in mice. The tumorigenic effect of ure-
thane directly depends on its dose (Mal-
kinson, 2001). BALB/c mice are considered 
susceptible to the development of lung tumor 
by urethane, and lung tumors can be modi-
fied by the influence of different modulatory 
agents (Malkinson and Beer, 1983; 
Uleckiene et al., 2005).  
In our study model, all urethane-treated 
mice of both genders developed lung tumors. 
No gender-related difference in the number 
of mice with lung tumors as well as in tu-
mors per mouse was detected between ure-
thane-treated male and female mice. The 
study data show that the number of pulmo-
nary tumors per mouse in the urethane-
treated males and in males treated with ure-
thane plus NaVP, lung tumors were observed 
statistically significantly more often in the 
non-castrated male group treated with ure-
thane in combination with NaVP. No signifi-
cant difference was found between analo-
gous female mice groups. No lung tumors 
were found in untreated intact control groups 
of both genders. Of all male mice in the 
NaVP-treated group, 13.3 % developed be-
nign lung tumors. No mice with lung tumors 
were found in the NaVP-treated female 
group.  
The study data show that NaVP in the 
urethane-treated BALB/c mice could act 
synergistically with urethane as an oncoge-
nic factor in male but not in female mice. 
Sex differences in mouse models of lung 
cancers were reported (Festing et al., 1994). 
The importance for lung oncogenesis in both 
spontaneous and carcinogen-induced pulmo-
nary cancers and spontaneous pulmonary ad-
enomas in mice is determined by multiple 
genetic loci that differ between female and 
male mice (Berndt et al., 2011). The study 
data show that NaVP in the urethane-treated 
castrated BALB/c male mice did not act syn-
ergistically with urethane as an oncogenic 
factor in male, and this fact indicates that tes-
tosterone plays an important role in the tu-
morogenic process in this model. There are 
no studies on NaVP influence on urethane-
related lung tumorigenesis in mice. 
Chronic NaVP toxicity studies showed 
that orally administered NaVP to Sprague 
Dawley rats and ICR (HA/ICR) mice at dos-
es of 80 and 170 mg/kg/day for two years 
developed an increased incidence of sub-
cutaneous fibrosarcoma in male rats at a 
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higher NaVP dosage level, and a dose-
related trend for an increased incidence of 
benign pulmonary adenomas was observed 
in male mice (McEvoy, 1991).  
NaVP increases the GABA turnover and 
potentiates GABAergic functions, reducing 
the activity of the GABA degrading enzymes 
(Godin et al., 1969; Loscher, 2002). NaVP 
may enhance neuronal responsiveness to en-
dogenous GABA. The effect of NaVP on 
cellular mechanisms may be sex-specific 
with the different response on basal GABA 
levels in males and females (Dodge et al., 
2000). The specificity of NaVP for GABA 
suggests that this interaction may be an im-
portant mechanism through which NaVP ex-
erts its pharmacological effects. The GABA 
A receptor is rapidly activated by NaVP in 
brain cells (Armijo et al., 2000). The GA-
BAergic neuronal activity was about two-
fold greater in male than female rats (Grattan 
and Selmanoff, 1997). A comparison be-
tween diestrous female rats and chronically 
castrated animals indicated that endogenous 
GABA release in ovariecomized rats was on-
ly 60–70 % of that in diestrous animals, 
while the basal GABA levels are also signif-
icantly reduced in estrogen-treated ovariec-
tomized rats (Ondo et al., 1982). In male 
rats, castration decreases the activity of GA-
BAergic neurons, suggesting that GABAer-
gic neurons are tonically stimulated by testo-
sterone. Testosterone replacement prevents 
the castration-induced decrease in GABA 
(Grattan and Selmanoff, 1993).  
GABA A receptors are also found out-
side synapses and on non-neural cells, can-
cerous cells included. GABA A receptor θ 
subunit (GABRQ) forms a functional iono-
tropic chloride channel (Fritschy et al., 1995; 
Bureu et al., 1997). Such extrasynaptic re-
ceptors have a high affinity for GABA and 
open the chloride channels at low ambient 
GABA concentrations (1 mM). This leads to 
changes in the membrane potential (Belelli et 
al., 2009). Opening the GABA A receptor 
chloride channels leads to a chloride efflux 
and depolarisation of the membrane (Zhao et 
al., 2011). The plasma cell membrane poten-
tial influences cell proliferation (Morokuma 
et al., 2008; Sundelacruz et al., 2009). Neu-
rotransmitters that change the membrane po-
tential contribute to the control of cell prolif-
eration (Martins and Pearson, 2008). GABA 
has been shown to regulate the proliferation 
of several cell types, including stem cells 
(Andang et al., 2008), cortical progenitor 
cells (Nguyen et al., 2003), immune cells 
(Bjurstom et al., 2008; Mendu et al., 2011), 
mouse chondrogenic ATDC5 cells 
(Tamayama et al., 2005), modulate the pro-
liferation, migration and differentiation of 
neuronal cells (Neelands et al., 1999; Haydar 
et al., 2000; Meier et al., 2003). 
The gene expression investigation of 
GABA receptors in tissues of non-small cell 
lung cancers and non-cancerous tissues 
showed that the gene expression of GABA 
receptor phenotypes was correlated with tu-
morigenesis and clinical prognosis (Zhang et 
al., 2013). The GABRQ is overexpressed in 
hepatocellular carcinoma cells, but not in a 
normal cell line, and GABA in the liver 
promotes the proliferation of cancer cells 
through GABRQ (Li et al., 2012). GABA 
could inhibit colon cancer migration associ-
ated with the norepinephrine-induced path-
way (Joseph et al., 2002). The effects of 
GABA and GABA receptors show that 
GABA-associated pathways could act posi-
tively or negatively in regulating cancer cell 
behavior. The injection of a combination of 
oestrogen and progesterone produced a 
greater reduction in GABA A receptor bind-
ing in mouse forebrain membranes, indicat-
ing that gonadal steroids contribute to the 
modulation of GABA A receptor binding in 
the cells of male and female mice (Akinci 
and Johnston, 1997).  
There could be other factors that may 
contribute to NaVP gender-related induction 
of cell proliferation and tumorigenesis re-
sponses, for example, the link of GABA 
mechanisms with the ion cotransporter activ-
ity expression regulating the intracellular 
chloride concentration. The depolarizing ef-
fects of GABA are promoted by the relative 
accumulation of chloride inside the cells, 
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leading to chloride efflux once GABA A re-
ceptor channels open. Intracellular chloride 
regulation and the control of GABA A re-
ceptor signaling are effected through K-Cl 
co-transporter (Delpire and Mount, 2002). 
To counteract their effects, the K-Cl cotrans-
porter exports these ions thus decreasing in-
tracellular chloride (Galanopoulou, 2008a). 
In male rat neurons, the K-Cl cotransporter is 
less expressed than in female (Galanopoulou, 
2008b). The possible mechanisms of K-Cl 
cotransporter activity was demonstrated in 
the modulation of tumor development and 
progression (Shen et al., 2004).  
NaVP has been shown to enhance the 
urinary excretion of chloride in Wistar rats of 
both genders, but the 24-hour chloriduretic 
response in male was significantly higher 
than in female rats (Grikiniene et al., 2005). 
GABA A receptor subunits are expressed in 
Wistar rat kidney proximal convoluted and 
straight tubules and in other tissues (Sarang 
et al., 2001; Li et al., 2012; Zhang et al., 
2013). Chloride is recognized to have an im-
portant role in tumor genesis: the intracellu-
lar chloride concentration would be one of 
the critical messengers in cell growth/pro-
liferation and differentiation processes 
(Shiozaki et al., 2006; Hiraoka et al., 2010; 
Ohsawa et al., 2010).  
NaVP is recognized as a novel class of 
histone deacetylases (HDAC) inhibitors that 
induce the differentiation of transformed 
cells and show antitumor properties in clini-
cal and preclinical studies, both in vitro and 
in vivo, by modulating multiple pathways 
including cell cycle arrest, cell differentia-
tion, apoptosis (Göttlicher et al., 2001; 
Kawagoe et al., 2002). Researchers have 
summarized preclinical and clinical data on 
positive NaVP effects in different types of 
tumors (Blaheta and Cinatl, 2002; Duenas-
Gonzalez et al., 2008). Recent data indicate 
that HDAC play a dual role in tumori-
genesis: oncosuppressive in the early stages, 
and oncogenic in established tumor cells in 
mice models (Santoro et al., 2013). Our 
study results show the opposite – negative – 
effect of NaVP on the progression of ure-
thane-induced lung tumors in the mice mod-
el. We have found no other gender-related 
mice studies on NaVP effects on tumorigen-
esis in the literature. Furthermore, there are 
data to show that NaVP increases the level of 
histone H3 acetylation in the brain with a 
gender-related effect: multiple NaVP selec-
tivity improved the early olfactory learning 
experience in male but not in female 8-day-
old mice pups (Burenkova et al., 2013).  
It is possible to hypothesize that NaVP, 
by changing GABA A receptor activity, the 
intracellular chloride level, and possibly 
modulating HDAC, plays an important gen-
der-related modulative role in urethane-
induced lung tumorigenesis in mice.  
In our study, there were cases of malig-
nant lung tumor in urethane- and urethane–
NaVP-treated mice groups. The effect of ure-
thane is known to be related with benign ad-
enoma or adenocarcinoma lung tumori-
genesis (Malkinson, 2001; Regala et al., 
2011). The data of our study show that 
NaVP may influence adenocarcinoma fre-
quency in urethane-caused lung tumor ge-
nesis. This effect was observed in tumors 
with the diameter more than 1.5 mm (a de-
tailed analysis of adenocarcinoma cases with 
the description of histological examination 
results will be published separately).  
Data of the present study show that 
NaVP, used together with urethane, syner-
gistically enhances urethane tumorigenicity 
in lungs of only non-castrated male BALB/c 
mice, but not in castrated ones. To check our 
findings on NaVP induction and promotion 
of gender-related lung tumorigenesis in the 
urethane mice model, the further studies on 
the importance of the NaVP gender-related 
action on pharmacological and patho-
physiological mechanisms are necessary. 
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